1-Methyl-2-oxopyrrolidine-3-carboxylic acid, 95.0%, 5g

Homomorpholine hydrochloride, 98.0%, 250mg

[ethyl(methyl)sulfamoyl]amine, 95%, 500mg

(R)-(-)-2,2-Dimethyl-1,3-dioxolane-4-ylmethyl p-toluenesulfonate, 95.0%, 5g

4,6-Difluoro-2-methyl-1H-benzo[d]imidazole, 95.0%, 10g

5-Bromo-1H-pyrrolo[2,3-b]pyridine-3-carboxylic acid, 95.0%, 10g

2,4,6-Trichloropyrimidine-5-carboxylic acid, 95.0%, 25g

6-Phosphogluconic acid trisodium salt dihydrate, 500 mg, glass packaging, >=98%

3-(4-Aminomethyl-phenyl)-propionic acid, 97%, 500mg

(4-(4-AMINO-3-METHYLPHENYL)PIPERIDIN-1-YL)(CYCLOPROPYL)METHANONE, 95.0%, 1g

Ethyl 2-hydroxyacetate, 95.0%, 100g

N-(4-Bromophenyl)-3-phenylpropanamide, 95.0%, 10g

Isoquinoline, 6-bromo-1-chloro-7-methoxy-, 98%, 250mg